UK industry and NHS members promote better access to innovation

The trade group representing the UK pharmaceutical industry has published a report highlighting significant variation in access to innovative medicines in the country.

The Association of the British Pharmaceutical Industry (ABPI), which teamed up with the NHS Confederation to author the research, said the data showed the importance of “collaboration between industry and the NHS to improve patient outcomes.”

The  document highlights four initiatives where effective partnerships between the National Health Service (NHS), patient organizations and industry have helped boost uptake of new treatments, in areas where access is more limited.